Skip to main content
. 2017 Mar 28;8(22):36566–36577. doi: 10.18632/oncotarget.16616

Figure 1. Overall survival and disease-free survival after pulmonary (n=129) and hepatic (n=116) metastasectomies are similar.

Figure 1

(A) Five-year overall survival rates after pulmonary metastasectomy and hepatic metastasectomy were 62.9% and 49.8%, respectively (p=0.13). (B) Three-year disease-free survival rates after pulmonary metastasectomy and hepatic metastasectomy were 50.7% and 45.5%, respectively (p=0.58).